Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GS vs MRNA✓SelectedUSD · MRNAGS vs MRNA performance historyLatest closeAs of-6.71%11/20
Stock and ETF performance explorer

GS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+4.2%
MRNA return
+697.5%
Excess return
-693.3%
Maximum drawdown
-31.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-6.7%-2.2%-4.5%-6.7%
7D-13.7%-12.7%-1.0%-13.6%
30D-12.6%-20.7%+8.1%-12.4%
3M-20.7%+46.3%-67.0%-20.9%
6M-18.7%+305.2%-324.0%-22.7%
YTD-8.7%+561.2%-570.0%-18.6%
1Y+4.2%+772.1%-767.9%-14.1%
All+4.2%+697.5%-693.3%-14.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling